Cargando…
1358. A Real-World Study of the Burden of Illness and Treatment Patterns Among Patients with Uncomplicated Urogenital Gonorrhea in the United States
BACKGROUND: Gonorrhea (GC) is a major public health threat in the US. The Centers for Disease Control and Prevention (CDC) estimated direct healthcare costs of &271 million in 2018. CDC 2015 guidelines (applicable up to December 18, 2020) recommended cephalosporin plus azithromycin for GC. We us...
Autores principales: | Preib, Madison T, Mitrani-Gold, Fanny S, Lan, Ziyu, Sun, Xiaoxi, Joshi, Ashish V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644239/ http://dx.doi.org/10.1093/ofid/ofab466.1550 |
Ejemplares similares
-
1429. Real-World Study of Patients with Uncomplicated Urinary Tract Infection in the United States: High-Risk Comorbid Conditions and Burden of Illness
por: Preib, Madison T, et al.
Publicado: (2021) -
1414. Real-World Study of Healthcare Resource Use and Costs Associated with Inappropriate and Suboptimal Antibiotic Use Among Females with Uncomplicated Urinary Tract Infection in the United States
por: Preib, Madison T, et al.
Publicado: (2021) -
186. A Systematic Literature Review on the Economic Burden of Illness in Gonorrhea
por: Martin, Amber, et al.
Publicado: (2020) -
Systematic Review and Meta-Analysis to Estimate the Treatment Effect and Inform a Noninferiority Margin for a Phase 3 Noninferiority Trial in Uncomplicated Urogenital Gonorrhea
por: Mitrani-Gold, Fanny S., et al.
Publicado: (2022) -
2839. Cost Burden of Patients with Oral Antibiotic Treatment Failure for Uncomplicated Urinary Tract Infection in the United States
por: Franklin, Meg, et al.
Publicado: (2023)